JAPAN – EU DEAL
May 1st, 2004
BY KEITH NUTHALL
A MUTUAL recognition agreement on good pharmaceutical manufacturing practice struck between Japan and the European Union (EU) will come into force on May 29, allowing certain medicines to be traded then sold without additional testing or certification. These include standard, homeopathic and vitamin treatments as listed in the agreement's annexe, and the scope will be reviewed in the future. The EU-Japan pharmaceutical trade is worth around Euro 10 billion annually, said the European Commission. * http://www.emea.eu.int/Inspections/MRAJP.html
A MUTUAL recognition agreement on good pharmaceutical manufacturing practice struck between Japan and the European Union (EU) will come into force on May 29, allowing certain medicines to be traded then sold without additional testing or certification. These include standard, homeopathic and vitamin treatments as listed in the agreement's annexe, and the scope will be reviewed in the future. The EU-Japan pharmaceutical trade is worth around Euro 10 billion annually, said the European Commission. * http://www.emea.eu.int/Inspections/MRAJP.html
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.